North America Advanced Wound Care Market Size, Share & Trends Analysis Report By Product (Moist, Antimicrobial), By Application (Chronic Wounds, Acute Wounds), By End-use (Hospitals, Specialty Clinics), And Segment - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The North America advanced wound care market size was estimated at USD 4.19 billion in 2023 and is projected to hit around USD 6.70 billion by 2033, growing at a CAGR of 4.8% during the forecast period from 2024 to 2033.

Key Takeaways:

  • The U.S. dominated the care market and accounted for the largest revenue share in 2023.
  • In Canada, the market for advanced wound care is estimated to witness the highest CAGR over the forecast period.
  • The hospital segment dominated the market and held the largest revenue share in 2023.
  • The home healthcare segment is expected to witness the fastest CAGR during the forecast period.
  • The moist wound care segment dominated the market and accounted for the largest revenue share of 71% in 2023.
  • The active wound care segment is anticipated to witness the fastest CAGR during the forecast period.
  • The chronic wounds segment dominated the market and held a significant revenue share in 2023
  • The acute wounds segment is expected to witness the fastest CAGR during the forecast period.

North America Advanced Wound Care Market Overview

The North America Advanced Wound Care market stands at the forefront of healthcare innovation, addressing the critical needs of patients with complex wounds. This burgeoning market is characterized by a spectrum of advanced technologies and therapies aimed at expediting the healing process and enhancing overall patient outcomes.

North America Advanced Wound Care Market Growth

The demand for advanced wound care products is increasing owing to the rising prevalence of chronic diseases across the region. Furthermore, increasing geriatric population is expected to impel market growth, as geriatric population has slow healing capabilities. For instance, as per a United Health Foundation report (published in May 2023), more than 55.8 million adults aged 65 and older lived in the U.S., accounting for about 16.8% of the nation's population in 2021, which is expected to propel market growth.

Advanced wound care products help to cure diabetic foot ulcers. For instance, according to JAMA Network, about 1.6 million people in the U.S. are affected by diabetic foot ulcers. Thus, an increase in number of diabetic patients is expected to increase the use of advanced wound care products. These products help in moisture retention and allow rapid healing of wounds internally as well as externally. Moreover, these products help in absorption of necrotic tissues and are effective in case of surgical site infection. Thus, healthcare professionals prefer to use advanced wound care products, which is anticipated to propel market growth over the forecast period.

The technological advancements in wound care products are projected to have a significant impact on the market. Some of the major technologically advanced products in this field are expected to be commercialized soon. For instance, nanoparticle-based wound healing and skin regeneration bioactive molecules have been developed, which when applied over the affected area, help sustain drug release and specifically improve the therapeutic effectiveness of drugs. Similarly, gene therapy products, which induce wound healing by introducing normal healthy genes into cells, are expected to be commercialized. For instance, in January 2023, Convatec launched the ConvaFoam in the U.S. ConvaFoam is a family of advanced foam dressings designed to meet the demands of medical professionals and their patients. This helped the company strengthen its presence in the U.S. market. Thus, with such advancements in wound care products, the market is expected to grow during the forecast period.

North America Advanced Wound Care Market Report Scope

Report Attribute Details
Market Size in 2024 USD 4.39 Billion
Market Size by 2033 USD 6.70 Billion
Growth Rate From 2024 to 2033 CAGR of 4.8%
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered Product, application, end-use, region
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Report Coverage Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Key Companies Profiled Smith & Nephew; Mölnlycke Health Care AB; ConvaTec Group PLC; Baxter International; URGO Medical; Coloplast Corp.; Medtronic; 3M; Derma Sciences Inc. (Integra LifeSciences); Medline Industries

 

North America Advanced Wound Care Market Key Drivers:

  • Technological Advancements: The continuous evolution of wound care technologies, including bioactive dressings, negative pressure wound therapy, and advanced wound care devices, is a driving force in the North American market.
  • Increasing Chronic Conditions: The rising prevalence of chronic conditions, such as diabetes and obesity, has led to an upsurge in chronic wounds, necessitating advanced wound care solutions for effective management and treatment.
  • Aging Population: With an aging population, there is a growing demand for advanced wound care products to address age-related conditions, including pressure ulcers and venous leg ulcers.
  • Rising Surgical Procedures: The escalating number of surgical procedures, coupled with a greater focus on postoperative care, has amplified the demand for advanced wound care products to accelerate the healing process and minimize complications.
  • Healthcare Infrastructure Development: Ongoing investments in healthcare infrastructure and a heightened emphasis on patient-centric care are contributing to the adoption of advanced wound care solutions across North America.

End-use Insights

The hospital segment dominated the market and held the largest revenue share in 2023. The growth of this segment can be attributed to an upsurge in surgical procedures and an increase in the number of hospital admissions. For instance, according to the National Library of Medicine, in 2022, 13.2 million people were hospitalized in the U.S. Thus, the increase in the number of hospitals and hospitalization rates is expected to help the market grow during the forecast period. Similarly, the rise in number of surgeries in the region is further helping the market grow. For instance, according to NIH, annually, about 64 million surgical procedures are carried out in the U.S. Therefore, the growing number of surgeries may lead to an increase in the use of advanced wound care products, propelling the market growth.

The home healthcare segment is expected to witness the fastest CAGR during the forecast period. During the COVID-19 pandemic, there was an increase in demand for home healthcare advanced wound care products. Moreover, the growing geriatric population is anticipated to propel the need for advanced wound care products further. The elderly population is more susceptible to chronic wounds, and with increasing age, wound healing ability of the body slows down. Moreover, according to Wound Care Learning Network, elderly people are more likely to be diagnosed with pressure ulcers. Thus, rise in the elderly population is expected to propel segment growth.

Product Insights

The moist wound care segment dominated the market and accounted for the largest revenue share of 71% in 2023. This dominance can be attributed to an increase in the number of wound cases and surgeries in the North American region. For instance, according to AHA Journals, approximately 40,000 children undergo congenital heart surgery in the U.S. As such surgeries take time to heal, advanced wound care products can help expedite recovery, thereby driving the market for advanced wound care during the forecast period.

The active wound care segment is anticipated to witness the fastest CAGR during the forecast period. This dressing offers advanced solutions for managing different chronic conditions such as diabetes, obesity, and vascular diseases. Therefore, with an increase in number of patients suffering from pressure ulcers and venous foot ulcers, the segment is expected to grow over the forecast period.

Application Insights

The chronic wounds segment dominated the market and held a significant revenue share in 2023.Increasing number of diabetic foot ulcers, venous pressure ulcers, and other chronic wounds is expected to drive the segment growth. For instance, according to Agency for Healthcare Research and Quality, more than 2.5 million people in the U.S. develop pressure ulcers every year. In addition, according to the CDC, in 2022, an estimated 37.3 million people, i.e., 11.3% of the total U.S. population, had diabetes. The rise in diabetic population is expected to increase the number of diabetic foot ulcer patients, thereby boosting market growth.

The acute wounds segment is expected to witness the fastest CAGR during the forecast period. The increasing number of different traumatic wounds, such as road accidents, is the major factor driving the segment. Moreover, the incidence of non-fatal injuries, which require medical attention, has increased in the U.S. For instance, according to data from the CDC, the incidence of non-fatal injuries in 2021 was estimated to be 23,455,654. Similarly, according to an article by Brady United Organization, about 316 people are shot every day in the U.S., out of which 210 survive. Thus, with an increasing number of acute wounds, the segment is expected to grow over the forecast period.

Regional Insights

  • The U.S. dominated the care market and accounted for the largest revenue share in 2023. This growth can be attributed to factors such as the presence of several key market players in this region, rising prevalence of chronic diseases in the country, well-established healthcare infrastructure, and favorable reimbursement policies and regulatory reforms in the healthcare sector. Thus, the above-mentioned factors are expected to propel market growth over the forecast period.
  • In Canada, the market for advanced wound care is estimated to witness the highest CAGR over the forecast period. This can be attributed to rising geriatric population, increasing government funding, and rising healthcare expenditure. For instance, as per a report by CBC, published in April 2022, about 7 million adults ages 65 and older live in Canada, accounting for 19% of the total population. The geriatric population is more susceptible to chronic diseases. Thus, these above-mentioned factors are expected to drive market growth over the forecast period.

Recent Developments

  • In January 2023, Convatec launched the ConvaFoam in the U.S., which is a family of advanced foam dressings designed to meet the demands of medical professionals and their patients. This helped the company strengthen its presence in the U.S. market.
  • In July 2023, Coloplast announced the acquisition of Kerecis. This acquisition would help Coloplast expand its wound care offerings.
  • In January 2022, Coloplast announced the acquisition of Triad Life Sciences. This acquisition enhanced Convatec's position in advanced wound care in the U.S. and granted it access to a unique and complementary technological platform that improves patient outcomes and helps provide advanced wound treatment. 

Key Companies & Market Share Insights

Smith & Nephew, Mölnlycke Health Care AB, ConvaTec Group PLC, Baxter International, Coloplast Corp., Medtronic, and 3M are some of the dominant players operating in the advanced wound care industry.

  • Medtronic has a global presence and operates from over 370 locations in approximately 160 countries.
  • Coloplast Corp. is a Denmark-based healthcare products and services company. It has a distribution network spread across 53 countries.
  • 3M develops, manufactures, and markets a range of products and services around the world. The company functions across four reportable segments: transportation & electronics; safety & industrial; healthcare; and consumer.

Derma Sciences Inc. (Integra LifeSciences) and Medline Industries some of the emerging market players.

  • Derma Sciences develops and markets medical technology solutions, such as implant systems, electrosurgery units, surgical laser systems, sterilization containers, OR lights, and surgical instruments.

Key North America Advanced Wound Care Companies:

  • Smith & Nephew
  • Mölnlycke Health Care AB
  • ConvaTec Group PLC
  • Baxter International
  • URGO Medical
  • Coloplast Corp.
  • Medtronic
  • 3M
  • Derma Sciences Inc. (Integra LifeSciences)
  • Medline Industries

Segments Covered in the Report

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the North America Advanced Wound Care market.

By Product 

  • Moist Wound Care
    • Foam Dressings
    • Hydrocolloid Dressings
    • Film Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Collagen Dressings
    • Other Advanced Dressings
  • Antimicrobial Wound Care
    • Silver
    • Non-silver
  • Active Wound Care
    • Biomaterials
    • Skin-substitute
    • Growth Factors

By Application 

  • Chronic Wounds
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Leg Ulcers
    • Other Chronic Wounds
  • Acute Wounds
    • Surgical & Traumatic Wounds
    • Burns

By End-use 

  • Hospitals
  • Specialty Clinics
  • Home Healthcare
  • Others

By Regional 

  • North America
    • U.S.
    • Canada

Frequently Asked Questions

The North America advanced wound care market size was estimated at USD 4.19 billion in 2023 and is projected to hit around USD 6.70 billion by 2033

The North America advanced wound care market is expected to grow at a compound annual growth rate of 4.8% from 2024 to 2033

Some key players operating in the North America advanced wound care market include Smith & Nephew; Mölnlycke Health Care AB; ConvaTec Group PLC; Baxter International; URGO Medical; Coloplast Corp.; Medtronic; 3M; Derma Sciences Inc. (Integra LifeSciences); Medline Industries.

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Product
                       1.1.2. Application
                       1.1.3. End-use
                       1.1.4. Regional
                       1.1.5. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. Nova one advisor’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                           1.3.5.1. Data for primary interviews in North America
                           1.3.5.2. Data for primary interviews in Europe
                           1.3.5.3. Data for primary interviews in Asia Pacific
                           1.3.5.4. Data for primary interviews in Latin America
                           1.3.5.5. Data for Primary interviews in MEA
                   1.4. Information or Data Analysis
                       1.4.1. Data analysis models
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                       1.6.1. Commodity flow analysis (Model 1)
                           1.6.1.1. Approach 1: Commodity flow approach
                       1.6.2. Volume price analysis (Model 2)
                           1.6.2.1. Approach 2: Volume price analysis
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
                       1.9.1. Objective 1
                       1.9.2. Objective 2
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Product outlook
                       2.2.2. Application outlook
                       2.2.3. End-use outlook
                       2.2.4. Mode of purchase outlook
                       2.2.5. Distribution channel outlook
                   2.3. Competitive Insights
Chapter 3. North America Advanced Wound Care Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Market Dynamics
                       3.2.1. Market driver analysis
                           3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
                           3.2.1.2. Introduction of innovative and advanced wound products
                           3.2.1.3. Rising geriatric population
                           3.2.1.4. Increasing number of road accidents, trauma cases, and burns
                           3.2.1.5. Increasing number of surgeries
                       3.2.2. Market restraint analysis
                           3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
                           3.2.2.2. Stringent regulations for manufacturing of wound care products
                   3.3. North America Advanced Wound Care Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier power
                           3.3.1.2. Buyer power
                           3.3.1.3. Substitution threat
                           3.3.1.4. Threat of new entrant
                           3.3.1.5. Competitive rivalry
                       3.3.2. PESTEL Analysis
                           3.3.2.1. Political landscape
                           3.3.2.2. Technological landscape
                           3.3.2.3. Economic landscape
                       3.3.3. Covid-19 Impact Analysis
Chapter 4. North America Advanced Wound Care Market: Product Estimates & Trend Analysis
                   4.1. Definitions and Scope
                       4.1.1. Moist
                       4.1.2. Antimicrobial
                       4.1.3. Active
                   4.2. Product Market Share, 2020 to 2033
                   4.3. Segment Dashboard
                   4.4. North America Advanced Wound Care Market by Product Outlook
                   4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
                       4.5.1. Moist wound care
                           4.5.1.1. Moist market estimates and forecast 2020 to 2033
                           4.5.1.2. Foam dressings
                               4.5.1.2.1. Foam dressings market estimates and forecast 2020 to 2033
                           4.5.1.3. Hydrocolloid dressings
                               4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2020 to 2033
                           4.5.1.4. Film dressings
                               4.5.1.4.1. Film dressings market estimates and forecast 2020 to 2033
                           4.5.1.5. Alginate dressings
                               4.5.1.5.1. Alginate dressings market estimates and forecast 2020 to 2033
                           4.5.1.6. Hydrogel dressings
                               4.5.1.6.1. Hydrogel dressings market estimates and forecast 2020 to 2033
                           4.5.1.7. Collagen dressings
                               4.5.1.7.1. Collagen dressings market estimates and forecast 2020 to 2033
                           4.5.1.8. Other advanced dressings
                               4.5.1.8.1. Other advanced dressings market estimates and forecast 2020 to 2033
                       4.5.2. Antimicrobial
                           4.5.2.1. Antimicrobial market estimates and forecast 2020 to 2033
                           4.5.2.2. Silver
                               4.5.2.2.1. Silver market estimates and forecast 2020 to 2033
                           4.5.2.3. Non-silver
                               4.5.2.3.1. Non-silver market estimates and forecast 2020 to 2033
                       4.5.3. Active
                           4.5.3.1. Active market estimates and forecast 2018 to 2030s, (USD Million)
                           4.5.3.2. Biomaterials
                               4.5.3.2.1. Biomaterials market estimates and forecast 2020 to 2033
                           4.5.3.3. Skin-substitute
                               4.5.3.3.1. Skin-substitute market estimates and forecast 2020 to 2033
Chapter 5. North America Advanced Wound Care Market: Application Estimates & Trend Analysis
                   5.1. Definitions and Scope
                       5.1.1. Acute Wounds
                       5.1.2. Chronic Wounds
                   5.2. Application Market Share, 2020 to 2033
                   5.3. Segment Dashboard
                   5.4. North America Advanced Wound Care Market by Application Outlook
                   5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
                       5.5.1. Chronic Wounds
                           5.5.1.1. Chronic wounds market estimates and forecast 2020 to 2033
                           5.5.1.2. Diabetic foot ulcers
                               5.5.1.2.1. Diabetic foot ulcers market estimates and forecast 2020 to 2033
                           5.5.1.3. Pressure ulcers
                               5.5.1.3.1. Pressure ulcers market estimates and forecast 2020 to 2033
                           5.5.1.4. Venous leg ulcers
                               5.5.1.4.1. Venous leg ulcers market estimates and forecast 2020 to 2033
                           5.5.1.5. Others chronic wounds
                               5.5.1.5.1. Others chronic wounds market estimates and forecast 2020 to 2033
                       5.5.2. Acute Wounds
                           5.5.2.1. Acute wounds market estimates and forecast 2020 to 2033
                           5.5.2.2. Surgical & traumatic wounds
                               5.5.2.2.1. Surgical & traumatic wounds market estimates and forecast 2020 to 2033
                           5.5.2.3. Burns
                               5.5.2.3.1. Burns market estimates and forecast 2020 to 2033
Chapter 6. North America Advanced Wound Care Devices: End-Use Estimates & Trend Analysis
                   6.1. Definitions and Scope
                       6.1.1. Hospitals
                       6.1.2. Specialty clinics
                       6.1.3. Home healthcare
                       6.1.4. Others
                   6.2. End-use Market Share, 2020 to 2033
                   6.3. Segment Dashboard
                   6.4. North America Advanced Wound Care Market by End-use Outlook
                   6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
                       6.5.1. Hospitals
                           6.5.1.1. Hospitals market estimates and forecast 2020 to 2033
                       6.5.2. Specialty clinics
                           6.5.2.1. Specialty clinics market estimates and forecast 2020 to 2033
                       6.5.3. Home healthcare
                           6.5.3.1. Home healthcare market estimates and forecast 2020 to 2033
                       6.5.4. Others
                           6.5.4.1. Others market estimates and forecast 2020 to 2033
Chapter 7. North America Advanced Wound Care Market: Regional Estimates & Trend Analysis
                   7.1. Regional market share analysis, 2023 & 2030
                   7.2. Regional Market Dashboard
                   7.3. Regional Market Snapshot
                   7.4. Regional Market Share and Leading Players, 2023
                       7.4.1. North America
                   7.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
                   7.6. North America
                       7.6.1. Market estimates and forecast, 2018-2030 (Revenue, USD Million)
                       7.7.2 U.S.
                           7.6.2.1. Key country dynamics
                           7.6.2.2. Competitive scenario
                           7.6.2.3. Regulatory framework
                           7.6.2.4. Reimbursement scenario
                           7.6.2.5. U.S. market estimates and forecasts, 2018-2030
                       7.7.3 Canada
                           7.6.3.6. Key country dynamics
                           7.6.3.7. Competitive scenario
                           7.6.3.8. Regulatory framework
                           7.6.3.9. Reimbursement scenario
                           7.6.3.10. Canada market estimates and forecasts, 2018-2030
Chapter 8. Competitive Landscape
                   8.1. Recent Developments & Impact Analysis, By Key Market Participants
                   8.2. Company/Competition Categorization
                       8.2.1. Innovators
                   8.3. Vendor Landscape
                       8.3.1. List of key distributors and channel partners
                       8.3.2. Key customers
                       8.3.3. Key company market share analysis, 2023
                       8.3.4. Smith & Nephew PLC
                           8.3.4.1. Company overview
                           8.3.4.2. Financial performance
                           8.3.4.3. Product benchmarking
                           8.3.4.4. Strategic initiatives
                       8.3.5. Mölnlycke Health Care AB
                           8.3.5.1. Company overview
                           8.3.5.2. Financial performance
                           8.3.5.3. Product benchmarking
                           8.3.5.4. Strategic initiatives
                       8.3.6. ConvaTec Group PLC
                           8.3.6.1. Company overview
                           8.3.6.2. Financial performance
                           8.3.6.3. Product benchmarking
                           8.3.6.4. Strategic initiatives
                       8.3.7. Baxter International
                           8.3.7.1. Company overview
                           8.3.7.2. Financial performance
                           8.3.7.3. Product benchmarking
                           8.3.7.4. Strategic initiatives
                       8.3.8. URGO Medical
                           8.3.8.1. Financial performance
                           8.3.8.2. Product benchmarking
                           8.3.8.3. Strategic initiatives
                       8.3.9. Coloplast Corp.
                           8.3.9.1. Company overview
                           8.3.9.2. Financial performance
                           8.3.9.3. Product benchmarking
                           8.3.9.4. Strategic initiatives
                       8.3.10. Medtronic
                           8.3.10.1. Company overview
                           8.3.10.2. Financial performance
                           8.3.10.3. Product benchmarking
                           8.3.10.4. Strategic initiatives
                       8.3.11. 3M
                           8.3.11.1. Company overview
                           8.3.11.2. Financial performance
                           8.3.11.3. Product benchmarking
                           8.3.11.4. Strategic initiatives
                       8.3.12. Derma Sciences (Integra LifeSciences)
                           8.3.12.1. Company overview
                           8.3.12.2. Financial performance
                           8.3.12.3. Product benchmarking
                           8.3.12.4. Strategic initiatives
                       8.3.13. Medline Industries, Inc.
                           8.3.13.1. Company overview
                           8.3.13.2. Financial performance
                           8.3.13.3. Product benchmarking
                           8.3.13.4. Strategic initiatives

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert